PMID: 9546947Jan 1, 1997Paper

The endothelin system in cardiovascular physiology and pathophysiology

Vascular Medicine
R J Parris, D J Webb

Abstract

Endothelin-1, a member of a novel family of regulatory peptides, is the most potent vasoconstrictor and pressor substance known. Endothelin-1 is a 21-amino-acid endothelium-derived peptide causing uniquely sustained vasoconstriction. In addition, endothelin-1 has pronounced effects on the coronary, renal and cerebral circulations, enhances responses to other vasoconstrictors, and is comitogenic. Recent studies have shown that the endothelins are essential for normal fetal development, and that endothelin-1 plays an important physiological role in the regulation of basal vascular tone and blood pressure in healthy humans. There is now also a wealth of evidence suggesting that endothelin-1 is a key mediator in a range of cardiovascular diseases associated with sustained vasoconstriction, such as chronic heart failure, and with vasospasm, such as subarachnoid haemorrhage. In addition, endothelin-1 appears to act in opposition to nitric oxide to promote the atherosclerotic process. There are a large number of oral and intravenously active endothelin antagonists entering clinical development and a number of clinical studies, particularly with endothelin receptor antagonists, are now under way. Such studies are beginning to define th...Continue Reading

References

May 1, 1992·British Heart Journal·S G RayH J Dargie
Aug 11, 1992·Mayo Clinic Proceedings·R J RodehefferJ C Burnett
Dec 17, 1992·The New England Journal of Medicine·K MooreK Badr
Dec 1, 1992·The Clinical Investigator·P LechleitnerB Puschendorf
Sep 1, 1992·The Journal of Clinical Investigation·J D Firth, P J Ratcliffe
Jun 15, 1992·Biochemical and Biophysical Research Communications·C J WaughD J Webb
Jul 1, 1992·Stroke; a Journal of Cerebral Circulation·I ZivM Sokolovsky
Jul 15, 1991·Biochemical and Biophysical Research Communications·Y OgawaH Imura
Aug 5, 1991·FEBS Letters·K HosodaH Imura
Oct 1, 1991·British Journal of Pharmacology·D J McCaig, S Aitken
Jan 1, 1991·Journal of Cardiovascular Pharmacology·K TakahashiS R Bloom
Jan 1, 1991·Journal of Hypertension·M NishimuraM Yoshimura
Sep 1, 1991·The Journal of Clinical Investigation·S KourembanasD V Faller
Oct 13, 1991·The New England Journal of Medicine·A LermanJ C Burnett
Mar 1, 1991·Stroke; a Journal of Cerebral Circulation·S YoshimotoS Murota
Mar 15, 1991·Annals of Internal Medicine·D J StewartD Langleben
Oct 2, 1990·European Journal of Pharmacology·P NambiD P Brooks
May 31, 1990·Biochemical and Biophysical Research Communications·F FyhrquistT Tikkanen
Jan 1, 1990·Life Sciences·Y ShiboutaK Nishikawa
Jul 1, 1990·The Journal of Clinical Investigation·M E LeeT Quertermous
May 1, 1990·Diabetologia·K TakahashiS R Bloom
Jul 31, 1990·Biochemical and Biophysical Research Communications·P MilnerG Burnstock
Jan 15, 1990·Biochemical and Biophysical Research Communications·M YoshizumiY Yazaki
Nov 1, 1988·Pflügers Archiv : European journal of physiology·T IshikawaT Masaki
Oct 16, 1989·Biochemical and Biophysical Research Communications·O ShinmiI Kanazawa
Oct 31, 1989·Biochemical and Biophysical Research Communications·P RoubertP Braquet

❮ Previous
Next ❯

Citations

Apr 2, 2004·Journal of Endodontics·Christine Y YuDao-Yi Yu
May 2, 2001·The Journal of Biological Chemistry·N O DulinT Voyno-Yasenetskaya
May 15, 2013·Clinical and Experimental Pharmacology & Physiology·Qiu-Hong GuoLi Chu
Dec 31, 2003·Circulation Research·Marit J BootAdriana C Gittenberger-de Groot
Feb 25, 2009·Current Cardiology Reports·Henry Gewirtz
Apr 1, 2014·Clinical Research in Cardiology : Official Journal of the German Cardiac Society·Mohamed Y Abd El RahmanHashim Abdul-Khaliq
Mar 13, 2001·Pharmacological Research : the Official Journal of the Italian Pharmacological Society·D GiannessiR L Vitale
Mar 19, 1999·European Journal of Pharmacology·J R Wu-WongT J Opgenorth
Feb 6, 1999·European Journal of Radiology·S K MorcosJ O Karlsson
Oct 3, 1998·Prostaglandins, Leukotrienes, and Essential Fatty Acids·M Albertini, M G Clement

❮ Previous
Next ❯

Related Concepts

Related Feeds

Basal Ganglia Cerebrovascular Disease

Basal ganglia cerebrovascular disease is a condition where the blood vessels in the basal ganglia are damaged or malfunction. Discover the latest research on basal ganglia cerebrovascular disease here.

Cardiovascular Disease Pathophysiology

Cardiovascular disease involves several different processes that contribute to the pathological mechanism, including hyperglycemia, inflammation, atherosclerosis, hypertension and more. Vasculature stability plays a critical role in the development of the disease. Discover the latest research on cardiovascular disease pathophysiology here.

Basal Ganglia

Basal Ganglia are a group of subcortical nuclei in the brain associated with control of voluntary motor movements, procedural and habit learning, emotion, and cognition. Here is the latest research.

Related Papers

American Journal of Hypertension
D J Webb, F E Strachan
Polski merkuriusz lekarski : organ Polskiego Towarzystwa Lekarskiego
M Negrusz-Kawecka
© 2022 Meta ULC. All rights reserved